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A novel approach to post-mastectomyradiation therapy using scannedproton beams. 
Introduction
Radiationtherapyhasbeenan effectivetool in the management of breastcancer [1] .
There are, however, concernsof late cardiac effects due to this treatment [2] [3] [4] [5] [6] [7] [8] .
Minimizing the dose to the heart has been the focus of various treatment improvementsincluding the use of heart blocks, CT-based planning, intensity modulation, etc. [9] . Breath holding is one of the most effective techniquesin reducingthe volumeof cardiactissuesfor conventional photontherapyusingtangent fields andis currentlypracticedin manyinstitutions [10, 11] , eventhoughits efficacy hasrecentlybeenquestioned [12] .
Despitestheseefforts, target volumescannotbe fully coveredwhile avoiding the cardiactissuesfor manypatients.This is true for post -mastectomyradiationtherapy (PMRT) with involvedinternalmammarynodes(IMN) for patientswith unfavorable cardiacanatomy.The standardPMRT treatmenttechniqueusesa combinationof photon/electron beamswith up to five fields involving multiple field matching.The optimization of such complex plans usually takes tremendousefforts in order to balance between IMN coverage, heart dose, hot and cold spots.
Thedistinctivephysicalpropertiesof theprotonbeam,i.e. theBraggpeak,offersnew possibilitiesin meetingthe challengesof PMRT. Severaltreatmentplanningstudies have demonstratedsigni ficant dosimetric advantagesfor reducing heart and lung doseswhile improving targetcoverage [13] [14] [15] [16] [17] . Thus, a proton PMRT clinical trial was startedat theinstitutionand early outcomesshowedthat the treatmentwas well tolerated [18] .
A first setof patientswastreatedwith enfacepassivelyscattered (PS)protonbeams.
While the treatmentsachievedthe primary goalsof minimizing the doseto the heart andlungs,andadequately coveringthe chestwall andinvolvednodes,several aspects of the treatmentwere less than ideal. The largesteffective field size (± 2 % dose homogeneity)for a PS beamis 22 cm in diameter.Most patientsthereforerequired abuttingfields, one for chestwall/IMN and one for the superiornodal targets.The matchlinebetweenthe two fields hadto be feathered, requiringtwo setsof hardware (apertureand compensators). The overall treatmentgenerally took 30 minutes.
Moreover, the lack of intensity modulation resulted in full skin dose and dose heterogeneities.
Protonpencilbeamscanning(PBS)is graduallybecomingavailablein protontherapy centersworldwide.Two of the mostdistinctivefeaturesof PBS,intensitymodulation andlargertreatment field size,arecritical elemen ts for improvingprotonPMRT.This work describes the institutionPBSPMRT treatment technique, its validation,aswell astheongoingeffortsperformedto ameliorateits delivery.
Materials and methods

Patient setupand CT scanning
The PMRT patients were positioned on a breast board used for conventional photon/electron treatment with botharmsup abovetheir head.Thebreastboardangle wasraisedto its limit to help with the surfaceimagingsystemusedfor patientsetup. 40 Gy(RBE)max doseto theesophagus RBE (relativebiologicaleffectiveness) corresponds to theratio of x-or -ray absorbed dose(Gy) to thatof a modality(Gy(RBE))to obtainthe samebiologicalendpoint. A RBE valueof 1.1is considered for protons [19] .
TPS-name , an in-house treatment planning software (TPS) with multi-criteria optimization(MCO) wasused.PMRT plansuseda PBSfield at a given gantryangle (30 from vertical). Beamspotswere placedon a fixed-size grid, extending15 mm aroundthe assignedtarget volume, with spotsspacedat one sigma (spot size). In depth,scanninglayerswerespacedby 0.8 × thedistal80 % Braggpeakwidth. Dueto machine limitations, an 8 cm range shifter was used to appropriatelyreach the superficialtargets. theinstitution's clinical machinepresents a 9 to 16 mm spotsizeas a function of energy. Pareto -optimal plans were generatedto meet the given constraints [20] . Finally, the set of Pareto -optimal planswerenavigatedto a desired state.
Beamrangeuncertainty
Beam range uncertainty due to inaccurateCT HU to proton stopping power conversionis alwaysa concernand the usualpracticeat the institution is to add an 
Treatment plan quality
As a result of the multi-criteria optimization,the target coverageand doseto the cardiacstructuresareoptimally balancedthroughintensitymodulation.Likewise,it is possible to reduce the skin dose to an acceptablelevel, especially in the supraclavicular nodal region, which is locateddeeperin the body. A nominal PBS PMRT planis presented in figure 2 .
The dosestatisticsfor the left-sidedPBSPMRT patientstreatedin the first 4 months of 2014(in total of 10) at theinstitutionarepresented in table1.
Skin dosevalidation
Measurements wereperformedwith a Markusparallelplateionizationchamberat 0, 1, 3, 5, and 7 mm depth, as well as in the center of the field (13 and 43 mm respectively),for both aforementioned treatmentplans.The resultsare presentedin figure 3. Thosemeasurements werein goodagreement ( 2 %) with theTPSvalues.
Treatment plan robustness
The robustness analysisresultsagainstsetupuncertainties arepresented in figure 4 as DVH envelopeswhich correspondto the maximum amplitudeof the perturbation associated with thespecifiedshifts,individually or simultaneously. As laterdiscussed, this can be considereda worst casescenario,and any combinationof shifts (± 3 mm,± 2 ) will be containedwithin thoseDVH boundaries. The DVH of the average distributionbasedon all theseshifts is presented as a thick dashedline. Overall, the target coveragefor chest wall, supraclav icular/axilla nodal regions remainsquite 
